Reglan ODT
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetic Gastroparesis
Conditions
Diabetic Gastroparesis
Trial Timeline
Jun 1, 2005 → —
NCT ID
NCT00139893About Reglan ODT
Reglan ODT is a pre-clinical stage product being developed by UCB for Diabetic Gastroparesis. The current trial status is completed. This product is registered under clinical trial identifier NCT00139893. Target conditions include Diabetic Gastroparesis.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00139893 | Pre-clinical | Completed |
Competing Products
20 competing products in Diabetic Gastroparesis